Many strategies have been used for decades to increase diversity and inclusion in the biopharmaceutical industry. The result: zero, and so the beat goes on.
It’s time for something bold: InternBio. InternBio is Boston’s biopharma internship workplace on college campus for talented college and high school students as interns. InternBio operates as a CRO exclusively for interns (contract research organization for interns). Opening soon at UMass Amherst Mount Ida Campus (Boston area). Our bold vision is an InternBio in every college supercluster.
At InternBio, you don’t need biopharma experience to get biopharma experience, and employers always find qualified, new, diverse talent ready for first job. Be Bold!
We get work to give work experience to students. With internship experience, college students can strengthen their job applications to biopharma companies, and high school students can strengthen their college applications.
Our training internships (interns learn then do), working internships, and training institutes are throughout the year, so employers in biopharma, and more generally in the life sciences industry, always find new, diverse talent ready to make an impact on Day 1 in first jobs in the industry.
The global life sciences industry is broad and includes biotechnology and pharmaceutical companies, as well as vaccine, medical device, diagnostics, generics companies, global health organizations, contract research organizations (service providers), health research institutes, and independent consultants; hereafter referred to as “companies.”
Guided by managers and mentors, interns engage in clinical trials, observational studies, and real-world evidence generation to support innovation in medicine, vaccine, medical device, diagnostics, and healthcare for patient health and global public health.
Conceptualized decades ago, initiated in 2008, and focused exclusively on interns since 2021 by a cure collaborative, InternBio collaborates across stakeholders and is powered by a stakeholder advisory group.
Many strategies have been used by life science companies and organizations for decades to increase diversity and inclusion in the life sciences/biopharma industry, among them are (a small sample, no specific order):
Mentoring and coaching
Awarding scholarships, grants, sponsorships, loans
Building visibility – to overcome the small-N problem
Building networks, partnerships, collaboratives
Leveraging alumni and other college groups
In-company resource groups, workstreams, initiatives
Getting hiring managers involved early
Conferences, career fairs, workshops, webinars, seminars
Summer and non-summer institutes
Job announcements to diverse colleges and universities
Talent recruitment visits to colleges, universities
Career awareness visits to elementary, middle and high schools
Adjusting recruitment and retention practices to minimize bias
Unconscious bias trainings and discussions
Looking to “new” sources for diverse talent
The result: zero or little sustainable impact, and so the discussions continue.
It’s time for something bold and differentiating — InternBio: The biopharma exclusively for interns.
Our bold vision is an InternBio in every college supercluster. Diversity solved!
Our mission is to help move more medicines and preventions with more diverse talent to more diverse patients everywhere, faster.
To Companies/Employers: We prepare new talent for you. At InternBio, you find qualified, diverse, new talent ready to make an impact on Day 1, saving your people managers the hand-holding time and cost.
To New Talent: We prepare you for employers. At InternBio, you don’t need biopharma experience to get biopharma experience. You get anytime internships, so you are ready to make an impact on Day 1 in your first job in biopharma.
InternBio is a member of the Kendall Square Association and the Cambridge Chamber of Commerce (Massachusetts).
HOW INTERNBIO SUPPORTS COMPANIES AND STUDENTS
InternBio, The biopharma exclusively for interns, partners with stakeholders to help drive our mission.
MORE TRAINING INSTITUTES COMING SOON IN . . .